Introduction
============

Activation of the posterior hypothalamus, zona incerta or lateral hypothalamus can elicit a variety of motor behaviors, including locomotion ([@B60]; [@B63]; [@B66]; [@B81]). A general finding was that the activity evoked from these areas was more complicated than the one elicited from motor regions of the brainstem ([@B44]), including the mesencephalic locomotor region and the medullary reticular formation ([@B31]). For example, stimulation of the lateral hypothalamus can result in varied responses ranging from feeding to predatory attack depending on context ([@B68]; [@B31]). In this work, we focus on targeting diencephalic areas of the brain containing monoaminergic cells, with the goal of understanding their multifaceted motor function.

[@B15] identified a series of dopaminergic nuclei named A8-16. Some of these are well linked with motor functions such as the substantia nigra pars compacta (A9), while the role of others have been less well described. One of these nuclei is the A11 region which is located in the posterior diencephalon abutting the third ventricle ([@B5]; [@B3]; [@B32]; [@B58]). These neurons are non-canonical dopaminergic cells which lack the dopamine reuptake transporter in mouse (DAT) ([@B32]; [@B79]). The A11 cell group appears to be evolutionarily conserved from zebrafish ([@B53]; [@B34]) to mammals ([@B3]). The broader connectome of the A11 has been under investigation; however, it has been shown to receive inputs from the parabrachial nucleus, infralimbic cortex, and the bed nucleus of the stria terminalis ([@B2]; [@B51]). One of the primary efferent targets of the A11 is the spinal cord -- sending collaterals at regular intervals into the gray matter, and has been proposed to be the primary source of spinal dopamine ([@B5]; [@B14]; [@B65]). While the functions of the A11 are not fully understood, it appears to have both anti-nociceptive and pro-nociceptive properties ([@B16]; [@B41]), pathologically it has been associated with Restless Legs Syndrome (RLS) ([@B13]), and 6-OHDA lesions of the area are associated with an increase in motor function ([@B50]) possibly by actions on dopamine receptor type 3 (D~3~) receptors ([@B12]; [@B50]).

One way in which A11 projections could control motor circuits is through direct modulation of spinal circuits, and indeed a sizable literature suggests that dopamine modulates the activity of motoneurons and interneurons within the lumbar spinal cord ([@B4]; [@B38]; [@B21]; [@B24]; [@B20]; [@B57]; [@B59]). Specifically, dopamine can alter the frequency and pattern of locomotor activity, by increasing spiking frequency robustly, and decreasing both the first spike latency and after hyperpolarization amplitude ([@B21]). The premotoneuronal excitatory drive onto motoneurons is also increased since dopamine can potentiate AMPA transmission in motoneurons by acting on D~1~ receptors ([@B22]), and increase mEPSC frequency in motoneurons ([@B21]). Finally, recent evidence suggests that dopamine acts on the sodium pump in motoneurons to directly increase an ultra-slow hyperpolarization ([@B49]). In sum, dopamine can modulate spinal motor function through an array of modulatory mechanisms. The larger family of monoamines ([@B30]; [@B38]; [@B37]) and trace amines ([@B20]; [@B23]), can also sculpt the pattern of activity evoked from spinal cord circuits. Sources of these monoamines include supraspinal projections ([@B54]; [@B67]).

Given the effects of monoamines on spinal motor circuits, this led to our hypothesis that activation of the A11 region in the freely behaving adult mouse would lead to changes in motor behavior. We found that photostimulation of the A11 region elicits motor behavior, and that dopamine neurons lacking DAT are present in the region ([@B74]). Part of this work was reported in an abstract and in a mini-symposium ([@B33]; [@B78]).

Materials and Methods {#s1}
=====================

Ethics Statement
----------------

All animal experiments were approved by the University of Calgary Health Sciences Animal Care Committee (Protocol: AC15-0016), following the Canadian Council for Animal Care guidelines. Animals were housed in a double-barrier facility for breeding.

Animals
-------

TH-IRES-Cre knock-in mice were used (a gift from Dr. Antoine Adamantidis, Universität Bern, Switzerland -- source; EM: 00254;B6.129X1-Thtm1(cre)Te/Kieg; European Mouse Mutant Archive) as well as DAT-IRES-Cre knock-in mice were obtained from Jackson labs \[B6.SJL-Slc6a3tm1.1(cre)Bkmn/J\]. Reporter mice were purchased from Jackson labs \[tdTomato mice: B6.Cg-Gt(ROSA)26Sortm14(CAG-TdTomato)Hze/J (Ai14)\]. vGluT2-Cre-tdTomato (gift from Dr. Marie-Claude Perreault, Slc17a7-IRES2-CRE, Jackson labs) and vGAT-ChR2-eYFP \[B6.Cg-Tg(Slc32a1-COP4^∗^H134R/EYFP)8Gfng/J, Jackson labs\] mice were also used. We then crossed the different lines to obtain TH-IRES-Cre homozygous, TH-IRES-Cre tdTomato, and DAT-IRES-Cre tdTomato heterozygous mice. Pairs of homozygous TH-IRES-Cre (male), DAT-IRES-Cre (female) or Ai14 (male or female) genotypes were mated, and the resulting heterozygous TH-IRES-Cre; Ai14 and DAT-IRES-Cre; Ai14 male offspring were used in subsequent experiments. All mice were genotyped with DNA extracted from ear notches using the Kapa mouse genotyping kit (Kapa Biosystems, Wilmington, MA, United States) according to manufacturer's instructions. TH-IRES-Cre mice were genotyped using mixed primer PCR employing TH-IRES-Cre-F (CCTGGTCTGGACACAGTGC), TH-WT-F (CAAGCACTGAGTGCCATTAGC) and TH-Com-R (AGAGGCCAGGAACACTCCTG). Amplification of wild-type genomic DNA yielded a 298 bp PCR product whereas amplification from the mutant locus yielded a 453 bp PCR product. Genotyping of the TH-IRES-tdTomato and DAT-IRES-Cre mice was performed similarly, using the primers recommended by the supplier (Jackson Labs, Bar Harbor, ME, United States). Mice were housed on a 12:12 h light:dark schedule (lights on at 07:00 -- off at 19:00) with *ad libitum* access to food and water. All behavioral experiments were performed in male mice between 8 and 16 weeks old.

Validation of TH-IRES-Cre Mice via Real Time qPCR
-------------------------------------------------

Total RNA was isolated from TH-IRES-Cre;CAG-LSL-tdTomato mouse microdissected brain regions (*n* = 7) A13, A11, and substantia nigra/ventral tegmental area (SN/VTA) using the RNeasy lipid tissue mini kit (Qiagen, Hilden, Germany) following manufacturer's recommendations. Reverse transcription was performed using the Superscript VILO IV kit (Thermo Fisher, Waltham, MA, United States). For the negative control groups, all components except the reverse transcriptase were included in the reaction mixtures. The primers for real time qPCR were mGAPD-F (GTGAAGGTCGGTGTGAACG) and mGAPD-R (TCGTTGATGGCAACAATCTC); TH-F (CCCAAGGGCTTCAGAAGAGC) and TH-R (ATCCTCGATGAGACTCTGCC); Cre-F (ACGCACTGATTTCGACCAGGTTCG) and Cre-R (CATTCTCCCACCGTCAGTACGTGAG). Real time qPCR was performed with PowerUp SYBR green master mix (Thermo Fisher, Waltham, MA, United States) and mouse GAPDH was utilized as the reference gene. The running protocol extended to 45 cycles in fast mode consisting of 95°C for 1 s, 60°C for 30 s using a Quantstudio 3 instrument (Thermo Fisher, Waltham, MA, United States). Standard curve experiments using control mouse brain RNA were determined using a 5 log range of cDNA concentrations yielding efficiencies ranging from 90 to 110% ([@B8]). Control reactions and those containing cDNA from the various brain regions were performed with 10 ng of template per reaction. PCR specificity was checked by dissociation curve analysis. Template controls yielded no detectable fluorescence. The relative mRNA abundance of TH and Cre in each sample were normalized to the abundance of GAPDH mRNA.

Optogenetics
------------

Under isoflurane anesthesia (1.5 %), mice were secured in a stereotaxic apparatus (Stoelting Co., Wood Dale, IL, United States), and glass capillaries were lowered into the brain of TH-IRES-Cre or TH-IRES-Cre; Ai14 mice (AP -2.3 mm; ML -0.1 mm from the bregma; DV -2.9 mm from the dura). Recombinant AAV carrying a fluorescently tagged channelrhodopsin 2, ChR2-eYFP (Addgene plasmid 20298, pAAV-EF1a-double floxed-hChR2(H134R)-eYFP-WPRE-HGHpA; titre: 3 × 10^12^ GC/ml; Virus Vector Core, UNC, Lot \# AV4844B) or eYFP (Addgene plasmid 20296, pAAV-EF1a-double floxed-eYFP-WPRE-HGHpA; 4 × 10^12^ GC/ml; Virus Vector Core, UNC, Lot \# AV4842C) were pressure injected using the Nanoject II apparatus (Drummond Scientific Company, Broomall, PA, United States). 210 nl of the virus were injected bilaterally, with a total volume of 420 nl per mouse.

Mice were returned to their home cage and left for at least 14 days to allow for transfection of the viral construct into A11 neurons. For optogenetic experiments, mono-fiber optic cannulas were stereotactically implanted into the A11 area (MF2.5-FLT, Doric, Quebec, QC, Canada) (AP -2.3 mm; ML, -0.1 mm from the bregma; DV -2.7 mm from the dura). Fiber optic cannulas were secured in place using dental cement (Metabond, Parkell, Brentwood, NY, United States and Dentsply, York, PA, United States). Mice were allowed to recover for at least 3 days before behavioral testing. We performed *post hoc* histology to confirm A11^ChR2^ transfection and ferrule placement.

Whole Cell Patch Experiments
----------------------------

In a separate series of experiments, we measured inward currents and spike activity using *in vitro* slice preparations to examine the effectiveness of A11^ChR2^ transfection. Young male TH-IRES-Cre; Ai14 mice (4--6 weeks postnatal) were deeply anesthetized with isoflurane and decapitated. Brains were then rapidly removed and immersed in 4°C slicing solution containing, in mM: 87 NaCl, 2.5 KCl, 0.5 CaCl~2~, 7 MgCl~2~, 25 NaHCO~3~, 25 D-glucose, 1.25 NaH~2~PO~4~, 75 sucrose saturated with 95% O~2~/5% CO~2~. 250 μm coronal sections were obtained using a vibratome (Leica), and allowed to recover for 1 + h in 95% O~2~/5% CO~2~ saturated, 30°C artificial cerebrospinal fluid (aCSF) containing (in mM): 126 NaCl, 2.5 KCl, 26 NaHCO~3~, 2.5 CaCl~2~, 1.5 MgCl~2~, 1.25 NaH~2~PO~4~, 10 glucose. All recordings took place in aCSF at 30--32°C perfused at a rate of 1 mL/min, with DNQX (10 μM, Tocris) or picrotoxin (100 μM, Sigma) applied via perfusion pump. Neurons were visualized with an upright microscope fitted with differential interference contrast and epifluorescence optics (UVICO, Rapp OptoElectronic) and camera (AxioCam MRm). Borosilicate pipettes (3--5 MΩ) were filled with internal solution containing (in mM) 108 K-gluconate, 2 MgCl~2~, 8 Na-gluconate, 8 KCl, 1 K~2~-EGTA, 4 K~2~-ATP, 0.3 Na~3~-GTP, 10 mM HEPES, 0.2 Alexa-488 hydrazide and 10 mg/mL biocytin. A fiber optic cable (105 μm core diameter) was placed 1--2 mm from the A11 using a manipulator to deliver light from a laser (473 nm, OptoGeni 473, IkeCool Corporation). Light intensity was measured by a Photodiode Power Sensor (Thorlabs). Maximally, 2.5 mW light was delivered to the tissue. Signals were amplified (Multiclamp 700B, Molecular Devices), low pass filtered at 1 kHz, digitized at 10 kHz (Digidata 1322, Molecular Devices, San Jose, CA, United States), and recorded (pClamp 9.2, Molecular Devices) for offline analysis of evoked or spontaneous synaptic currents (Clampfit, Molecular Devices; MiniAnalysis, Synaptosoft).

Behavior
--------

For *in vivo* experiments the light source (473 nm, LRS-0473-GFM, Laserglow Technologies, Toronto, ON, Canada) was connected to an implanted ferrule with a fiber optic cable (200 μm core diameter, Doric Lenses, Quebec City, QC, Canada). The laser was controlled by TTL pulses delivered using a Master 8 pulse stimulator (A.M.P.I., Jerusalem, Israel). The blue light was delivered for 3 min (20 Hz, 10 ms pulse width, 15 mW).

Each mouse was tested for 9 min (3 min pre, 3 min light, 3 min post) for five consecutive days. Behavior was recorded using a vertically mounted video camera and *post hoc* analyzed with the TopScan video tracking software (Clever Sys Inc., Reston, VA, United States). For c-Fos immunolabelling, animals were sacrificed 2 h after light stimulation. Behavioral testing was performed in a 70 cm × 70 cm × 50 cm high open field chamber with opaque walls. Each mouse was habituated to the chamber for 3 days for 1 h per day before testing. On test days, mice were habituated for 30 min before testing and trials were performed at the same time of day. Mice were transferred to and from a behavioral testing room for day-to-day testing. Mice were housed singly in standard cages (SafeSeal Plus Mouse Green Line GM500, Techniplast, Italy, 501 cm^2^ floor) with no environmental enrichment.

The Clever Sys tracking software divided movement into three categories:

1.  Immobility/No movement: Immobility is defined by both speed and motion measures (animal body change in consecutive frames expressed as a percentage). Immobility bouts over 15 successive frames were estimated when speed was \<60 mm/s and the change in motion was \<1% change in animal body position.

2.  In Place Activity: Animal stays in one place with some observed activity such as grooming, sniffing, stretching, rearing, but the animal is not immobile.

3.  Locomotion. Distance traveled: The mouse physically moves or displaces itself from one location to another with a minimum prescribed speed of greater than 60 mm/s and a minimum distance of 100 mm. Locomotor bouts: the number of times animal moves from one place to another place. If the animal continuously moves, it is counted as one single bout. Locomotor duration: the amount of time the mouse spends in locomotion.

Immunohistochemistry
--------------------

Mice were sacrificed with isoflurane (2%) and transcardially perfused with phosphate-buffered saline (PBS), followed by 10% formalin in PBS. Brains were placed in 10% formalin for 12 h followed by 30% sucrose phosphate buffer (PB) for cryoprotection. 30 μM coronal brain sections were obtained using a cryostat (Leica CM1850 UV, Leica Biosystems, Richmond Hill, ON, Canada). The sliced brain sections were collected in a staggered fashion and placed into four consecutive wells. Rinses were performed before and between incubations with 0.1 M PBS, followed by one 20 min wash in Tris-buffered saline containing Triton (TBSt; pH 7.4, with 0.1% TritonX-100). Sections were incubated in blocking solution (5% donkey and 5% goat serum in PBS) for 1 h, and blocking solution was used in subsequent antibody incubations. The primary antibodies used were rabbit anti-TH, sheep anti-TH (1:1000, Abcam Inc., Toronto, ON, Canada), chicken anti-GFP (1:1000, Aves Laboratories, Tigard, OR, United States), rabbit anti-c-Fos (1:1000, EMD Millipore, Billerica, MA, United States), rabbit anti-RFP (1:5000, Rockland Immunochemicals Inc, Limerick, PA, United States) and rabbit anti-AADC (1:250, Novus Biologicals, Littleton, CO, United States). The secondary antibodies used were Alexa-564-conjugated donkey anti-rabbit, Alexa-488-conjugated donkey anti-sheep, Alexa-488-conjugated goat anti-chicken, Alexa-647-conjugated donkey anti-sheep (1:1000, Molecular Probes, Burlington, ON, Canada), biotinylated donkey anti-rabbit and Cy3-conjugated streptavidin (1:500, Jackson Immuno Research, West Grove, PA, United States). Free-floating brain sections were then mounted onto Superfrost^TM^ slides, coated with Vectashield^TM^ (H-1000, Vector, Burlingame, CA, United States) and cover-slipped. Fluorescent images were collected using the following microscopes; Nikon Eclipse C1si spectral confocal microscope, Nikon A1R MP+ and Olympus BX51. The objectives used were 4X (NA 0.13), 20X PLAN APO DIC (NA 0.75), 20X PLAN FLUOR (NA 0.75), 60X PLAN APO IR (NA 1.27) for Nikon Eclipse C1si spectral confocal microscope. The lasers used were centered on 488 nm (515/30 nm emission filter) and 561 (590/50 nm emission filter). The objectives used were 10X DIC L N1 (NA 0.30), 20X PLAN FLUOR MImm DIC N2 (NA 0.75), 60X PLAN APO IR WI DIC N2 (1.27) for the Nikon A1R MP+ microscope. The lasers used were centered at 403 nm, (450 nm emission filter) 488 nm (525 nm emission filter), and 562 nm (595 nm emission filter), respectively using pinhole radius of 12.7--21.5 microns on Nikon A1R MP+ microscope. The 20X images were taken with z-step 0.5 or 1 μm, 60X with z-step 0.15 μm. Stacked images were acquired by averaging four frames with a resolution of 1024 × 1024 or 512 × 512. Some images were acquired using a Panoramic FLASH II digital slide scanner (3DHISTECH inc., provided by Quorum Technologies) equipped with a Lumencor SPECTRA light source and PCO.edge sCMOS camera. Off-line image processing included maximal intensity projections conducted using NIS-Elements Advanced Research Version 4.10 as well as adjustments of brightness and contrast in Adobe Photoshop. Cell counting was accomplished by a person blinded to the study using ImageJ (NIH Image, Bethesda, MD, United States). We counted five sections containing the area of interest per animal.

Data Analysis and Statistics
----------------------------

Statistical analyses were performed in GraphPad Prism 6. Unpaired Student's *t*-tests were conducted comparing between two independent groups (e.g., A11^eYFP^ vs. A11^ChR2^). When assumptions of normality were violated, a Mann--Whitney test was performed instead of a *t*-test. A two-way repeated measures analysis of variance (ANOVA) was conducted to examine changes between two groups (i.e., A11^eYFP^ vs. A11^ChR2^) across time. When a significant main effect or interaction was found, Tukey *post hoc* comparisons were conducted. When assumptions of normality were violated on the ANOVA, non-parametric Friedman tests were done with a Dunn's multiple comparison tests when significant main effects were found. Repeated measures one-way ANOVA (RM-ANOVA) tests were conducted to examine changes within a group (i.e., A11^eYFP^ vs. A11^ChR2^) in different conditions (before, during, just after light-activation of the A11). When a significant main effect or interaction was found, Bonferroni multiple *post hoc* comparisons tests were conducted. Data are reported as the mean ± standard deviation (SD) and *P* \< 0.05 values were considered significant. When data did not pass normality tests, the median is reported with 25--75% ranges. When histograms were used (**Figure [6](#F6){ref-type="fig"}**) both the median and mode were used to report data.

Results
=======

Classes of Cells Within the A11 Region
--------------------------------------

We used a viral approach to identify classes of cells within the A11. The viral transfection efficiency was confirmed by injecting an AAV-DIO-ChR2-eYFP construct into A11 region in TH-IRES-Cre-tdTomato reporter mice (**Figures [1A](#F1){ref-type="fig"}--[C](#F1){ref-type="fig"}**, *n* = 4). We found that 96% (SD = 1.7%) of ChR2-eYFP neurons expressed TH-tdTomato (**Figure [1D](#F1){ref-type="fig"}**) in the A11 region. To confirm that Cre expression levels correlated with the expression levels of endogenous TH, real time qPCR analyses were performed on RNA isolated from TH-expressing brain regions A13 (A), A11 (B), and SN/VTA (C) (**Figure [1D](#F1){ref-type="fig"}**). Expression of TH and Cre, respectively, were normalized to the expression of the reference gene GAPDH. The normalized expression of Cre was consistently lower than that of TH, with levels ranging from 36 to 43%, depending on the brain region. All of the animals analyzed were heterozygous for the Cre transgene so the expected result was that Cre mRNA levels would be 50% of TH mRNA levels. Based on these results we expect that Cre mRNA levels will be close to TH mRNA levels in homozygous TH-IRES-Cre mice. Next, we confirmed in TH-IRES-Cre mice that the viral injections were restricted to the A11 region. **Figure [2](#F2){ref-type="fig"}** shows that the expression of ChR2-eYFP^+^ was spatially restricted to neurons from the A11 region (**Figure [2A](#F2){ref-type="fig"}**) following Cre-dependent viral expression. Other neighboring TH expressing regions, like the VTA, substantia nigra pars compacta and A13 did not show evidence of eYFP reporter expression (**Figures [2Ac,Ba--c,Ca--c](#F2){ref-type="fig"}**, respectively).

![Anatomical characterization of TH-IRES-Cre A11 neurons following transfection with AAV-DIO-ChR2-eYFP. **(A)** Diagram showing the middle region of the A11 area in the mouse (Bregma --2.46). The red frame represents the area where representative micrographs were taken. 3V, third ventricle; PF, parafascicular thalamic nucleus; fr, fasciculus retroflexus; PH, posterior hypothalamic nucleus. **(B)** TH-IRES-Cre tdTomato mice expressing channelrhodopsin-2 -- enhanced yellow fluorescent protein (ChR2-eYFP) in A11. Confocal image showing A11 neurons expressing ChR2-eYFP bilaterally (stitched image consisting of 4 20X images). Scale bar 100 μm. **(C)** Higher magnification (60X zoom) of boxed areas **(a,b)** in **B**, Scale bar 20 μm. **(Da)** Schematic map showing the injection site of virus with the Cre-dependent ChR2 construct tagged with ChR2-eYFP or eYFP alone into the A11 of TH-IRES-Cre mice. **(Db)** Pie graph showing that 96% of ChR2-eYFP positive cells in A11 co-express tdTomato (*n* = 4). **(Dc)** Quantitative real-time PCR analysis of ratio of Cre mRNA to that of TH mRNA in A13, A11 and substantia nigra/ventral tegmental area (SN/VTA) brain regions.](fncir-12-00086-g001){#F1}

![ChR2-eYFP expression is restricted to A11 area. Immunohistochemistry targeted against eYFP (green) and TH (magenta) showing restricted ChR2-eYFP expression to A11. **(Aa,b)** ChR2-eYFP expression in A11 following Cre-dependent viral expression (DAPI, blue was used to label the cell nuclei). **(Ac)** Higher magnification (20X) of boxed TH^+^-IR neurons in substantia nigra pars compacta. **(Ba,b,c)** No ChR2-eYFP expression in the ventral tegmental area (VTA). **(Ca,b,c)** No ChR2-eYFP expression in A13. Images **(Aa,b, Ba,b, Ca,b)** acquired with Olympus slide scanner 20X magnification, scale bar 500 μm; **(Ac, Bc, Cc)** Higher magnification confocal images of boxed area in **b (Ab, Bb, Cb)**, scale bar 100 μm.](fncir-12-00086-g002){#F2}

Next, we examined the co-localization of TH^+^-IR cells with A11^ChR2^ cells to identify the neurotransmitter phenotype of the cells transfected within the A11 region of TH-IRES-Cre mice. Similar to recent reports ([@B35]) we found that 54% of A11^ChR2^ expressing cells were co-localized with TH^+^-IR (*n* = 4, ChR2 mean = 132, SD = 32.01, TH^+^-IR mean = 105.5, SD = 11.03; co-localizing mean = 71.75, SD = 15.97, data not shown). In our previous work, we established that the large diameter cells which constitute the A11 region in mice are a non-canonical class of dopaminergic neurons that lack the Dopamine Transporter (DAT) ([@B32]) which was replicated in a report that used a DAT-GFP reporter line ([@B79]). We further confirmed these findings using our DAT-Cre-tdTomato reporter line (data not shown). We then tested for non-classical types of monoaminergic cells within the A11 region. These neurons only express the AADC enzyme and can produce various monoamines and trace amines ([@B74]). We found evidence for AADC cells lacking TH in the A11 region (**Figure [3](#F3){ref-type="fig"}**) which suggest the presence of putative D-cells in the A11 region ([@B26]). In TH-tdTomato^+^ mice, we found that 35% of TH-tdTomato^+^/TH^-^-IR neurons were also AADC^+^ in the A11 region (*n* = 5, TH-tdTomato^+^/TH^-^-IR mean = 185.8, SD = 129.1, TH-tdTomato^+^/TH^-^-IR/AADC^+^ mean = 64.4, SD = 38.14; **Figure [3](#F3){ref-type="fig"}**). Taken together these results suggest that approximately 70% of transfected cells are capable of releasing dopamine and other monoamines such as serotonin (5-HT) or trace amines.

![Aromatic [L]{.smallcaps}-amino acid decarboxylase (AADC) expression in A11 TH-IR neurons. **(A)** Immunohistochemistry targeted against AADC (green) and TH^+^-IR (magenta) as well as native TH-tdtomato (red) expression showing that a proportion of A11 TH-tdTomato^+^/TH^-^-IR neurons were also AADC^+^ in TH-IRES-Cre tdTomato mice. 20X magnification, scale bar 100 μm. **(B)** Enlarged image showing AADC^+^/TH-tdTomato^+^/TH^-^-IR (arrows) and AADC^+^/TH-tdTomato^+^/TH^+^-IR neurons (arrowheads). 20X magnification, scale bar 50 μm.](fncir-12-00086-g003){#F3}

Since there is evidence of localization of dopamine with co-transmitters such as peptides, glutamate or GABA, we asked whether co-localization of dopamine neurons in the A11 with GABA or glutamate could be detected. **Figure [4](#F4){ref-type="fig"}** illustrates there is evidence of a small number of vGluT2^+^ cells within the A11 region. However, there was no vGluT2^+^-TH^+^-IR co-localization in the A11 region, compared to the arcuate nucleus of hypothalamus (**Figures [4A,B](#F4){ref-type="fig"}**). While vGluT2 was the most likely target subpopulation we also examined Allen Brain Atlas data and found strong expression of vGluT3, however, no evidence for vGluT1 staining in the A11 vicinity was found. Our data indicates a lack of vGAT colocalization in TH^+^-IR neurons of A11 (**Figures [4C,D](#F4){ref-type="fig"}**). We did see evidence for some vGAT^+^ somata within the A11 region.

![A11 TH^+^-IR neurons lack vGluT2 and vGAT expression. **(A,B)** Immunohistochemistry targeted against TH (magenta) in a vGluT2-reporter (green) mouse. (Aa) vGluT2 expressing neurons are plentiful in the arcuate nucleus of hypothalamus, scale bar 200 μm. **(Ab--d)** Higher magnification of boxed area **(Aa)**, Scale bar 20 μm. vGluT2 is present in the arcuate nucleus of hypothalamus which served as a positive control. Arrow indicates a double positive TH^+^-IR A11 neuron expressing vGluT2. **(Ba)** TH^+^-IR neurons in A11 region, scale bar 200 μm. **(Bb--d)** Higher magnification of boxed area **(Ba)**, scale bar 10 μm. We observed a few vGluT2 expressing neurons in the A11 region but these neurons lacked TH^+^-IR (arrow). **(C,D)** Immunohistochemistry targeted against TH (magenta) in a vGAT-reporter (green) mouse. **(Ca)** Large number of vGAT expressing GABAergic interneurons are observed in cortex, scale bar 200 μm. **(Cb--d)** Higher magnification of boxed area **(Ca)**, scale bar 10 μm. Arrows indicate GABAergic interneurons expressing vGAT and TH^+^-IR fibers and puncta are also observed. **(Da)** TH^+^-IR neurons in A11 region, scale bar 200 μm. **(Db--d)** Higher magnification of boxed area **(Da)**, scale bar 10 μm. TH^+^-IR neurons in A11 region lack any vGAT expression.](fncir-12-00086-g004){#F4}

Photostimulation of the A11 Region Increases Motor Activity
-----------------------------------------------------------

Given that the viral injections were restricted to the A11 region, we tested the feasibility of using TH-IRES-Cre mice as a tool to photostimulate A11 neurons.

First, we tested, using brain slices, if the A11^ChR2^-cells could elicit sodium (Na^+^) spikes or currents following photostimulation. Pulses of blue light (473 nm) were delivered via an optical fiber, which successfully elicited photocurrents in A11^ChR2^ cells (**Figure [5](#F5){ref-type="fig"}**). We also determined that trains of Na^+^ spikes were reliably elicited at frequencies up to 20 Hz (**Figure [5Dc](#F5){ref-type="fig"}**), which was the frequency we adopted for *in vivo* studies.

![Photostimulation of A11 cells induces c-Fos protein expression in A11 ChR2-eYFP neurons *in vivo* and action potentials *in vitro*. ChR2-eYFP expressing (*n* = 4) mice and eYFP control (*n* = 4) mice were stimulated with 473 nm light at 15 mW with 20 Hz, 10 ms pulses, 2 h prior to sacrifice. **(Aa)** A11 neurons from ChR2-eYFP light stimulated mouse (stitched image consisting of 4 20X images; scale bar 100 μm). **(Ab)** Higher magnification (60X zoom) of boxed area (scale bar 20 μm). **(B)** Photostimulation of A11 eYFP neurons (no ChR2) *in vivo* does not result in significant co-localization of c-Fos in A11-eYFP^+^ cells (scale bar 100 μm). **(C)** Bar graph summarizing changes in the percentage of neurons co-expressing c-Fos in ChR2-eYFP (*n* = 4) versus eYFP (*n* = 4). **(D)** Real-time optical stimulation with 473 nm light reliably elicits spikes in A11 neurons *in vitro*. Example of a photocurrent recorded in voltage-clamp mode, elicited by 473 nm blue light **(Db)**. Trains of light pulses (10 ms pulse-width) at 20 Hz frequency evoked spike activity **(Dc)**. **(Da)** Schematic showing approach. ^∗∗^*P* \< 0.01.](fncir-12-00086-g005){#F5}

We then asked whether light pulses directed to the A11 region *in vivo* could also successfully activate A11^ChR2^-cells. We implanted a fiber optic cannula unilaterally 0.1 mm lateral to the midline just above A11 region to bilaterally stimulate A11. We photostimulated both A11^ChR2^ or A11^eYFP^ mice at 20 Hz for 3 min (same parameters as for behavior), sacrificed them 2 h later to allow for c-Fos expression and prepared brain slices to probe for c-Fos^+^-expression, which is increased in neurons following depolarization (**Figures [5A,B](#F5){ref-type="fig"}**). We found that in 10 animals (ChR2 *n* = 5, eYFP *n* = 5) A11^ChR2^-cells were more likely to be also c-Fos^+^ compared to cells infected with control eYFP ^+^ construct (**Figure [5C](#F5){ref-type="fig"}**, ChR2 *n* = 5, eYFP *n* = 5, *U* = 0, *P* = 0.004, Mann--Whitney test). These data suggest that the A11^ChR2^-cells can be photo-activated *in vitro* and *in vivo* and that the neurons from the A11 region that are infected with control eYFP^+^ construct are not activated by the same light stimulation parameters.

Next, we addressed the functional role of A11 neuronal activation in freely moving mice. We assessed movement in the open field test in animals expressing A11^ChR2^ or in A11^eYFP^. The mice were habituated to the open field for 1 h daily for 3 days and then tested for a fixed period on each of five consecutive days. Prior to testing, mice were habituated to the open field for 30 min with optical fibers attached. We recorded baseline activity 3 min prior to light activation, directly followed by 3 min of 20 Hz, 10 ms pulse width of light (473 nm) and 3 min of post-light activation (**Figure [6A](#F6){ref-type="fig"}**).

![Photostimulation of A11 in awake behaving mice initiates and modulates locomotion. **(A)** Schematic showing the implantation site of the light ferrule, along with a schematic of the experimental plan. **(B)** Locomotor distance was significantly increased during photostimulation in ChR2 animals compared to eYFP-control mice (averaged over 5 days). Baseline was corrected. **(C,D)** ChR2 mice displayed significantly more distance traveled **(C)** and locomotion bouts **(D)** during blue light stimulation compared with light-off conditions. There was no significant difference between the three conditions in eYFP control mice (*n* = 7) (average over 5 days). **(E)** 87.3% of ChR2 trials (blue bars) crossed the threshold during photostimulation while only 38.2% of the eYFP trials (gray bars) crossed the threshold (5 days, all trials), looking at individual trials the median time to cross the threshold was 40 s for ChR2 mice, and 60 s for eYFP mice. The red bars on the left of both graphs indicate the percentage of trials where the threshold was not crossed. These data suggest that photostimulation of A11 can initiate and modulate locomotion. ^∗∗^*P* \< 0.01; ^∗∗∗^*P* \< 0.001.](fncir-12-00086-g006){#F6}

In the A11^ChR2^ cohort only, qualitatively we noticed that animals reacted immediately to the light by changing behavior in a variety of ways (e.g., postural changes, starting to groom, turning, sniffing, stretching, and rearing but the animal is neither locomoting nor immobile). Collectively, these behaviors were quantified as changes in "in-place activity." When we compared the effect of light between the groups (A11^ChR2^ and A11^eYFP^, baseline corrected; difference = value - baseline) we found significant differences between the groups for in place activity (A11^ChR2^ *n* = 16, 803 ± 741 mm; A11^eYFP^ -391 ± 503 mm; *n* = 7, *U* = 11, *P* = 0.0007, Mann--Whitney test; data not shown).

These animals would then generally begin to locomote after engaging in these activities (see **Supplementary Video [1](#SM1){ref-type="supplementary-material"}**). When we further examined these changes in the A11^ChR2^ cohort, photostimulation increased the distance traveled by 86.0% (**Figure [6C](#F6){ref-type="fig"}**; *n* = 16, *Q* = 18.9, *P* \< 0.0001, Friedman test) and the total number of locomotor bouts by 75.6% (**Figure [6D](#F6){ref-type="fig"}**; *n* = 16, *Q* = 16.6, *P* = 0.0002, Friedman test, see methods for definitions). In contrast, this was not observed in the A11^eYFP^ control group (**Figure [6C](#F6){ref-type="fig"}**, *n* = 7, Q = 2.0, *P* = 0.5; **Figure [6D](#F6){ref-type="fig"}**, *n* = 7, *Q* = 1.5, *P* = 0.5, Friedman test). When we compared the effect of light between the groups (A11^ChR2^ and A11^eYFP^, baseline corrected, difference = value - baseline) we found significant differences for the following parameters: locomotion (A11^ChR2^ *n* = 16, 1551 ± 1503 mm; A11^eYFP^ -149 ± 665 mm; *n* = 7, *U* = 10, *P* = 0.0005, Mann--Whitney test), and bouts of locomotion (A11^ChR2^, *n* = 16, 1.88 ± 4.09 bouts; A11^eYFP^, -3.18 ± 3.36 bouts; *n* = 7, *U* = 13, *P* = 0.001, Mann--Whitney test). We did not observe an effect of day \[2-way ANOVA with repeated measures, *F*(4.6) = 0.04, *P* = 1\].

Next, we determined the latency for changes in movement behavior after photostimulation. For this, we averaged the data (distance in mm) into 10 s bins and set a threshold (mean of the pre-light distance traveled over 3 min, + two times SD) for each individual trial and determined the latency of crossing the threshold. We examined all trials (*n* = 80, all days, all animals) and found that 87.3% of the A11^ChR2^ trials crossed threshold during light activation with a median latency of 40 s (25--75% percentile 20--80, **Figure [6E](#F6){ref-type="fig"}**). In contrast, only 38.2% of the A11^eYFP^ mice trials (*n* = 35, all days, all animals) crossed threshold with a median latency of 60 s (25--75% percentile 48--130 **Figure [6E](#F6){ref-type="fig"}**).

When we examined all photostimulation trials on a trial-to-trial basis, there was no significant correlation between basal locomotor activity and the light mediated effect (distance traveled (mm); *r* = -0.1, *P* = 0.1) due to variability in the data (mean = 43.80 mm, SD = 272.2, median = 2.6 mm). Taken together our data suggest that photostimulation of A11 affects both the movement during locomotion as well as the in-place activity.

Discussion
==========

Previous work has shown that the diencephalic A11 cell group contains neurons that project to the spinal cord and its effects are associated with pain control ([@B16]), migraine ([@B9]), cataplexy ([@B45]), and possibly a role in RLS ([@B13]). Our work provides evidence that activation of A11 increases motor behavior, including locomotor and non-locomotor events. The A11 was shown to depress firing of dorsal horn neurons responding to noxious input ([@B16]; [@B73]), through a D~2~ receptor-mediated mechanism ([@B72]). Similar effects on trigeminal nociception have been also reported ([@B1]). But dopamine has also been shown to be pro-nociceptive through D~5~ receptors expressed in the spinal cord ([@B41]). This complex sensorimotor role is shared with other monoamines such as 5-HT and noradrenaline ([@B54]; [@B43]), and is partly dependent on the diversity of monoamine receptor subtypes. Indeed, this sensorimotor modulation may be related to expression of movement as hypothesized for RLS ([@B13]). As outlined below, dopamine's actions on motor circuits are also diverse. This points to a role in both pain and motor function where the actions of dopamine can modulate multiple circuits within the spinal cord to fine-tune sensorimotor function. A further diversity of A11 actions could be linked to the sex of the animals. Our work used male mice and it is possible that results in females may differ, since work in rats has shown a sexual dimorphism in the A11 descending projections ([@B46], [@B47]) and recent work show spinal D~5~ receptors in the dorsal horn contributing to hyperalgesia in male but not female mice ([@B41]). Since male rats have a greater density of A11 fibers in the ventral horn it is possible that A11 stimulation in males would show greater motor effects compared to females.

Mode of Action
--------------

Our previous work established that in mice, the A11 is primarily dopaminergic but lacks DAT ([@B32]) which has also been confirmed using DAT reporter mice ([@B79]). In the A11 system, this DAT^-^ mechanism may increase synaptic dopamine concentration, augmenting dopamine's actions within the spinal cord.

Data from the neonatal rat and mouse shows that bath application of dopamine restricted to the thoracolumbar spinal region modulates fictive locomotor patterns ([@B29]; [@B27]; [@B77]; [@B4]; [@B10]; [@B19]; [@B25]; [@B57]; [@B59]). This dopamine-evoked excitation of mammalian spinal locomotor circuits occurs through D~1/5~ receptors ([@B39]; [@B55]; [@B4]; [@B38]; [@B19]; [@B21]) although a role for D~2/3/4~ receptors exists ([@B25]). In particular, D~1/5~ receptors appear to enhance the stability of ongoing locomotion but D~2/3/4~ receptors appear to contribute to a slowing of the rhythm ([@B57]), and may access part of the pattern generator through recurrent collaterals ([@B25]). In adult spinalized mice, D~1~ receptors appear to contribute more than D~5~ receptors to locomotion, based on the use of D~5~ receptors KO mice ([@B36]). Since this study used a mixed cohort of male and female mice, and recent evidence suggests that D~5~ receptors are present in higher numbers in the spinal cord of male mice ([@B41]), a role for D~5~ receptors in locomotion cannot be excluded. Dopamine fibers projecting from the diencephalon (A11 region) are present in the ventral horn of the mouse adult spinal cord, an area where dopamine receptors and motor circuits are located ([@B80]; [@B76]; [@B51]; [@B82]). The release of dopamine and its metabolites occurs in the ventral horn of neonatal rats during fictive locomotion ([@B28]) and in the spinal cord of adult rats following walking ([@B18]). Moreover, administration of D~1~ agonists in adult mice with a complete thoracic injury elicited bouts of stepping ([@B36]). Finally, the critical role played by dopamine transmission in locomotion is highlighted by the fact that L-DOPA-elicited air stepping in intact neonatal rats is blocked by intrathecally introduced dopamine receptor antagonists ([@B61]; [@B40]). Work by several groups ([@B16]; [@B73]) has shown that stimulation of A11 in adult animals has effects on nociception, acting both pre- and post-synaptically on neurons within the dorsal horn of the spinal cord ([@B73]), and inhibited by dopaminergic antagonists. Taken together, these data suggest that A11 activation can influence spinal cord circuits via dopamine, and dopamine can have several actions on spinal motor circuits.

Like many nuclei the A11 is known to project to other areas of the brain, including the amygdala, prefrontal cortex ([@B71]; [@B69], [@B70]), and dorsal raphe ([@B48]). Indeed diencephalon-specific pathways to the brainstem, including the medullary reticular formation and the mesencephalic locomotor region have been shown in the past ([@B64]; [@B62]). We expect therefore that the A11 connectome is more extensive than has been published. Therefore while spinal cord connections may be responsible for the observed effects, A11 collaterals projecting to other brain regions may also be involved. Within the A11 we found neurons that were positive for vGluT2 and negative for vGAT. But we did not find cells that co-localized dopamine and vGluT2. However, vGluT3 neurons are found in the A11 vicinity (Allen Brain Atlas) so it is possible that dopamine neurons could still contain glutamate. Our data show some vGAT^+^ positive neurons in the A11 region, agreeing with data from the Allen Brain Atlas, and we saw no vGAT^+^-TH^+^-IR neurons.

Effects on Motor Activity
-------------------------

We found that photostimulation of the A11 region produced immediate responses that, although varied, always led to locomotion. The delay in the initiation of locomotion is consistent with early reports of stimulation of this region ([@B44]; [@B66]). There are several possibilities for this delay. The A11 network may form a reverberating positive-feedback local network resulting in an increase in spike output over time, and the fact that vGluT2 neurons are in the A11 region point to this being a possibility. We do not feel that the delay may be due to fast inhibitory neurons being recruited since our data do not show vGAT^+^ somata within the A11. On the other hand, low concentrations of dopamine bind to high-affinity D~2/3/4~ receptors, producing inhibition. At higher dopamine concentrations, expected with prolonged spiking within the A11, a switch to excitation could occur ([@B11]). Alternatively, an interesting observation is that within the isolated spinal cord preparation of the rodent, bath application of dopamine produces a delayed activation of the network often being an order of magnitude slower compared to 5-HT application ([@B20]). An action of dopamine on trace amine receptors (TAAR1) has been proposed to account for this delay in the rat ([@B7]; [@B20]) and a similar mechanism operating *in vivo* could partly account for the delays noted here. A component of the A11 cells activated were presumably D-cells ([@B26]), which lack TH but contain AADC, based on the Allen Brain Atlas, and our own work. Little is known about the storage and release of dopamine (or other transmitters) from these cells. Work by [@B75] shows evidence of hypothalamic AADC^+^/TH^-^ cells that lack VMAT2. Therefore neurotransmitter release from D-cells likely occurs differently from the standard vesicular-based dopamine release. Recent evidence shows that the hypothalamic neurons containing glutamate, GABA, and dopamine cells can be subdivided into 62 distinct subpopulations where neuropeptides are co-localized in a distinct manner ([@B52]). While our data show that the A11 contains a small number of vGluT2 neurons we did not see any co-expression with TH^+^ neurons, but vGluT3 expression was not tested here, and is observed in the A11 region, therefore glutamate co-localization in TH^+^ neurons may still be possible. Our RT-PCR data showed that the levels of Cre mRNA are between 36 and 41% of TH mRNA in heterozygous TH-tdTomato mice, which is close to our expectations of 50% levels. Slightly lower levels of Cre mRNA may be due to the possibility that the locus of TH transcription is more active than the locus of Cre transcription. On the other hand, this supports the idea of active transcription of TH mRNA in the absence of the translation of TH protein which was highlighted in a recent report ([@B42]). In this regard, we feel that future attempts using other techniques such as double fluorescent in situ hybridization or single cell RNA-seq may provide additional insights on molecular and cellular diversity in phenotypes of TH cells in the A11. The most conservative interpretation of our data is that at a minimum 54% of ChR2-TH^+^ neurons were dopaminergic, and a possibility remains that this percentage could be higher. Since we did not observe co-localization of vGAT or vGluT2 with TH^+^-IR, we conclude that the stimulated population includes mainly dopaminergic neurons, D-cells, and an undefined neuronal population.

Conclusion
==========

This is the first study to show that stimulation of the A11 has pro-locomotory effects. This adds to the hypothesized role of the A11 in RLS ([@B13]; [@B51], [@B50]), where patients suffer from an uncontrolled desire to move their limbs associated with modulation of D~3~ receptors in the spinal cord ([@B39]). Further clues to the role of the A11 in motor control will require selective activation and inactivation of spinally projecting axons to differentiate direct from indirect actions on spinal cord functions. Given the robust effects of dopamine on modulation of spinal circuits ([@B58]) this would be an interesting target to investigate. A11 forms one of many nuclei in the diencephalon and midbrain that have motor effects and connect with nuclei in the brainstem and spinal cord ([@B31]; [@B6]; [@B17]; [@B56]). A more complete understanding of their role will require parallel recording and stimulation of these distinct regions during complex motor behavior.

Author Contributions
====================

KK performed the experiments, analyzed the data, and wrote and edited the paper. CJ-X participated in performing experiments, analyzed data, edited the paper, and participated in experimental design. SS participated in performing experiments, edited the paper, and participated in experimental design. TF edited the paper, analyzed the data, and participated in performing experiments. LY, SEAE, and CHTK performed experiments, analyzed data, and edited the paper. JB participated in experiment design and edited the paper. PW conceived the experiments, supervised the research, and edited and wrote the paper.

Conflict of Interest Statement
==============================

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

We acknowledge grant support from the Canadian Institutes of Health Research and from the HALO initiative, HBI. KK and LY received studentship support from Alberta Innovates Health Solutions; KK also received support from the Fong studentship (Hotchkiss Brain Institute) and Eyes High (University of Calgary). We acknowledge technical assistance from Ms. Jillian Ejdrygiewicz, Ms. Claude Veillette, and Ms. Michelle Tran. We also acknowledge technical support from the RUN/HBI-AMP Core Microscopy, the HALO Behavioral Facility, and Dr. Frank Visser from the Molecular Core Facility at the University of Calgary. We acknowledge assistance from Dr. Luis de Lecea's lab (Stanford University) in ferrule implantation. The TH-IRES-Cre mice were a kind gift from Dr. Antoine Adamantidis (Universität Bern). The vGluT2 mice were a kind gift from Dr. Marie-Claude Perreault (Emory University).

Supplementary Material
======================

The Supplementary Material for this article can be found online at: <https://www.frontiersin.org/articles/10.3389/fncir.2018.00086/full#supplementary-material>

###### 

Photostimulation of A11^ChR2^ mouse during the open field test.

###### 

Click here for additional data file.

[^1]: Edited by: Brian R. Noga, University of Miami, United States

[^2]: Reviewed by: Aaron M. Lambert, Harvard University, United States; Shuichi Ueda, Dokkyo Medical University, Japan; Shawn Hochman, Emory University, United States
